European Finance News

OncoMethylome Sciences (EBR:ONCOB) LabCorp Presents Positive Results On GST-Pi/APC Methylation Test For Detection Of Prostate Cancer

🕔11/4/2008 5:03:00 PM

OncoMethylome Sciences (EBR:ONCOB) LabCorp presents positive results on GST-Pi/APC methylation test for detection of prostate cancer OncoMethylome's methylation technology for improving the detection of prostate cancer was validated in a study presented by LabCorp.

Read Full Article

Essentially Group Limited (LON:ESN) Masters Appoints Essentially Group

🕔11/4/2008 5:03:00 PM

Essentially Group Limited (LON:ESN) For Immediate Release 4 November 2008

Read Full Article

BTS Group AB (STO:BTS) (publ) Growth Despite Negative Development In APG

🕔11/4/2008 5:01:00 PM

BTS Group AB (STO:BTS) BTS Group AB (publ)

Read Full Article

Ad Hoc: Pfeiffer Vacuum Technology AG: Record Volume Of New Orders In 3rd Quarter. Dollar Impacts Sales And Profitability.

🕔11/4/2008 4:53:00 PM

Pfeiffer Vacuum Technology AG / Interim report / Ad hoc: Record volume of new orders in 3rd quarter. Dollar impacts sales and profitability. Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

OctoPlus N.V. (AMS:OCTO) OctoPlus To Present At Rodman And Renshaw Conference

🕔11/4/2008 4:47:00 PM

OctoPlus N.V. (AMS:OCTO) OctoPlus N.V. (Euronext: OCTO), the drug delivery company, announces today that its CEO will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New York next week.

Read Full Article

Imtech N.V. (AMS:IM) Breakthrough For Imtech In Scandinavia Through Acquisition Of NVS

🕔11/4/2008 4:33:00 PM

Imtech N.V. (AMS:IM) * Imtech now also one of the largest technical market players in Sweden and Norway * Basic position obtained in Finland

Read Full Article

Pronova BioPharma ASA (OSL:PRON) Continued Strong Growth For Pronova BioPharma

🕔11/4/2008 4:07:00 PM

Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma posted strong third quarter results, driven by robust end-user demand and consistent performance at the Sandefjord plant. In-sourcing of intermediaries has facilitated the increase of the production forecast for 2009 to 1 400-1 500 tonnes. Positive results for the GISSI-heart failure trial were published at the European Society of Cardiology in August. Both primary endpoints were met.

Read Full Article